DE122004000034I1 - Verfahren zur entfernung von Gallsa}re von einem Patienten sowie die alkylierte zusammensetzungen dafür. - Google Patents

Verfahren zur entfernung von Gallsa}re von einem Patienten sowie die alkylierte zusammensetzungen dafür.

Info

Publication number
DE122004000034I1
DE122004000034I1 DE200412000034 DE122004000034C DE122004000034I1 DE 122004000034 I1 DE122004000034 I1 DE 122004000034I1 DE 200412000034 DE200412000034 DE 200412000034 DE 122004000034 C DE122004000034 C DE 122004000034C DE 122004000034 I1 DE122004000034 I1 DE 122004000034I1
Authority
DE
Germany
Prior art keywords
patient
reaction product
alkylating agent
ch2ch2
nitrogen atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE200412000034
Other languages
English (en)
Inventor
W Mandeville
Stephen Holmes-Farley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Geltex Pharmaceuticals Inc
Original Assignee
Geltex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22980525&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE122004000034(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Geltex Pharmaceuticals Inc filed Critical Geltex Pharmaceuticals Inc
Publication of DE122004000034I1 publication Critical patent/DE122004000034I1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/52—Amides or imides
    • C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C08F220/60—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide containing nitrogen in addition to the carbonamido nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F26/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/02—Alkylation
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/44—Preparation of metal salts or ammonium salts
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L39/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions of derivatives of such polymers
    • C08L39/02—Homopolymers or copolymers of vinylamine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE200412000034 1994-06-10 1995-06-05 Verfahren zur entfernung von Gallsa}re von einem Patienten sowie die alkylierte zusammensetzungen dafür. Pending DE122004000034I1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25843194A 1994-06-10 1994-06-10
PCT/US1995/007181 WO1995034585A1 (en) 1994-06-10 1995-06-05 Process for removing bile salts from a patient and alkylated compositions therefor

Publications (1)

Publication Number Publication Date
DE122004000034I1 true DE122004000034I1 (de) 2005-02-24

Family

ID=22980525

Family Applications (3)

Application Number Title Priority Date Filing Date
DE200412000034 Pending DE122004000034I1 (de) 1994-06-10 1995-06-05 Verfahren zur entfernung von Gallsa}re von einem Patienten sowie die alkylierte zusammensetzungen dafür.
DE69511861T Expired - Lifetime DE69511861T2 (de) 1994-06-10 1995-06-05 Verfahren zur entfernung von gallsaüre von einem patienten sowie die alkylierte zusammensetzungen dafür
DE1995611861 Active DE122004000034I2 (de) 1994-06-10 1995-06-05 Verfahren zur entfernung von Gallsaure von einem Patienten sowie alkylierte zusammensetzungen dafür

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE69511861T Expired - Lifetime DE69511861T2 (de) 1994-06-10 1995-06-05 Verfahren zur entfernung von gallsaüre von einem patienten sowie die alkylierte zusammensetzungen dafür
DE1995611861 Active DE122004000034I2 (de) 1994-06-10 1995-06-05 Verfahren zur entfernung von Gallsaure von einem Patienten sowie alkylierte zusammensetzungen dafür

Country Status (21)

Country Link
US (12) US5693675A (de)
EP (2) EP0909768A3 (de)
JP (1) JP3931217B2 (de)
KR (1) KR100271693B1 (de)
CN (1) CN1150217C (de)
AT (1) ATE184027T1 (de)
AU (1) AU698752C (de)
CA (1) CA2191478C (de)
DE (3) DE122004000034I1 (de)
DK (1) DK0764174T3 (de)
ES (1) ES2135743T3 (de)
FR (1) FR04C0021I2 (de)
GR (1) GR3031702T3 (de)
IL (2) IL114073A (de)
LU (1) LU91100I2 (de)
MX (1) MX9606171A (de)
NL (1) NL300159I2 (de)
NZ (1) NZ288076A (de)
RU (1) RU2160742C2 (de)
TW (1) TW474813B (de)
WO (1) WO1995034585A1 (de)

Families Citing this family (130)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5487888A (en) * 1993-05-20 1996-01-30 Geltex, Inc. Iron-binding polymers for oral administration
US5607669A (en) * 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
US5929184A (en) * 1993-06-02 1999-07-27 Geltex Pharmaceuticals, Inc. Hydrophilic nonamine-containing and amine-containing copolymers and their use as bile acid sequestrants
US6129910A (en) * 1993-06-02 2000-10-10 Geltex Pharmaceuticals, Inc. Water-insoluble noncrosslinked bile acid sequestrants
TW474813B (en) * 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
US6203785B1 (en) 1996-12-30 2001-03-20 Geltex Pharmaceuticals, Inc. Poly(diallylamine)-based bile acid sequestrants
US5925379A (en) * 1997-03-27 1999-07-20 Geltex Pharmaceuticals, Inc. Interpenetrating polymer networks for sequestration of bile acids
US6423754B1 (en) 1997-06-18 2002-07-23 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with polyallylamine polymers
US5985938A (en) * 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US6566407B2 (en) 1997-11-05 2003-05-20 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
US6083497A (en) 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
US6267952B1 (en) * 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
US7048917B1 (en) 1998-01-09 2006-05-23 Genzyme Corporation Fat-binding polymers
US6264937B1 (en) * 1998-01-09 2001-07-24 Geltex Pharmaceuticals, Inc. Fat-binding polymers
US6299868B1 (en) 1999-07-14 2001-10-09 Geltex Pharmaceuticals, Inc. Fat-binding polymers
US6294163B1 (en) 1998-10-02 2001-09-25 Geltex Pharmaceuticals, Inc. Polymers containing guanidinium groups as bile acid sequestrants
JP4749649B2 (ja) * 1998-10-12 2011-08-17 中外製薬株式会社 リン酸結合性ポリマー
TW568788B (en) * 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
DE19850817A1 (de) 1998-11-04 2000-05-11 Basf Ag Modifizierte kationische Polymere, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Papierherstellung
US6271264B1 (en) * 1998-12-01 2001-08-07 Geltex Pharmaceuticals, Inc. Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants
WO2000063259A1 (en) 1999-04-16 2000-10-26 Abbott Laboratories Process for producing cross-linked polyallylamine hydrochloride
US6190649B1 (en) 1999-04-23 2001-02-20 Geltex Pharmaceuticals, Inc. Polyether-based bile acid sequestrants
MXPA02000492A (es) * 1999-07-14 2002-07-02 Geltex Pharma Inc Polimeros enlazantes de grasas, opcionalmente combinados con inhibidores de lipasas.
US6362266B1 (en) 1999-09-03 2002-03-26 The Dow Chemical Company Process for reducing cohesiveness of polyallylamine polymer gels during drying
US6180754B1 (en) 1999-09-03 2001-01-30 The Dow Chemical Company Process for producing cross-linked polyallylamine polymer
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
RS50397B (sr) * 2000-07-28 2009-12-31 F. Hoffmann-La Roche Ag., Farmaceutska smeša
US8263112B2 (en) * 2000-11-20 2012-09-11 Sorbent Therapeutics, Inc. In vivo use of water absorbent polymers
WO2002040039A2 (en) 2000-11-20 2002-05-23 Dow Global Technologies Inc. In vivo use of water absorbent polymers
EP1358886B1 (de) 2000-11-28 2010-07-07 Mitsubishi Tanabe Pharma Corporation Exkretionsbeschleuniger für eine akkumulative chlorverbindung
AT409630B (de) * 2000-12-13 2002-09-25 Dsm Fine Chem Austria Gmbh Alkylierung von n-bzw. amino- oder ammoniumgruppen haltigen, vernetzten polymeren
WO2002066543A1 (en) 2001-02-16 2002-08-29 Genzyme Corporation Method of drying a material having a cohesive phase
JP2004526778A (ja) * 2001-04-18 2004-09-02 ジェンザイム コーポレーション 脂肪族ポリアミンを用いるｘ症候群の処置方法
CA2444587C (en) * 2001-04-18 2008-10-21 Genzyme Corporation Pharmaceutical compositions of low salt polyallylamine hydrochloride
EP1923064B1 (de) 2001-04-18 2017-06-28 Genzyme Corporation Verwendung von Aminpolymeren zur Minderung des Serumglukosegehaltes
WO2002085380A1 (en) * 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for treating gout and reducing serum uric acid
ES2304437T3 (es) * 2001-04-18 2008-10-16 Genzyme Corporation Uso de colesevelam o de hidrocloruro de sevelamer para reducir la glucosa serica.
WO2002085379A1 (en) * 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for improving vascular access in patients with vascular shunts
US7041280B2 (en) * 2001-06-29 2006-05-09 Genzyme Corporation Aryl boronate functionalized polymers for treating obesity
US7049345B2 (en) * 2001-06-29 2006-05-23 Genzyme Corporation Fat-binding polymers
US6600011B2 (en) 2001-10-09 2003-07-29 Genzyme Corporation Process for purification and drying of polymer hydrogels
AT411463B (de) 2002-09-03 2004-01-26 Dsm Fine Chem Austria Gmbh Verfahren zur herstellung von alkylierten n- bzw. amino-, ammonium- oder spirobicyclischen ammoniumgruppen haltigen, vernetzten polymeren
AT414237B (de) * 2002-09-03 2006-10-15 Dsm Fine Chem Austria Gmbh Verfahren zur herstellung von quaternären halogen-alkyl-ammoniumsalzen
US7220406B2 (en) * 2002-10-22 2007-05-22 Genzyme Corporation Method for promoting bone formation
AP2501A (en) 2003-05-30 2012-10-22 Ranbaxy Lab Ltd Substituted pyrrole derivatives
US7608674B2 (en) 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7385012B2 (en) * 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7767768B2 (en) * 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7335795B2 (en) * 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) * 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
JPWO2005092349A1 (ja) 2004-03-26 2008-02-07 田辺三菱製薬株式会社 インスリン抵抗性改善剤
US7556799B2 (en) * 2004-03-30 2009-07-07 Relypsa, Inc. Ion binding polymers and uses thereof
US8192758B2 (en) * 2004-03-30 2012-06-05 Relypsa, Inc. Ion binding compositions
US7854924B2 (en) 2004-03-30 2010-12-21 Relypsa, Inc. Methods and compositions for treatment of ion imbalances
US8282960B2 (en) * 2004-03-30 2012-10-09 Relypsa, Inc. Ion binding compositions
US7429394B2 (en) * 2004-03-30 2008-09-30 Relypsa, Inc. Ion binding compositions
WO2005094384A2 (en) 2004-03-30 2005-10-13 Ilypsa, Inc. Methods and compositions for treatment of ion imbalances
JP2008510022A (ja) * 2004-08-12 2008-04-03 ヴァーサマトリックス・アクティーゼルスカブ ビーズ状架橋ポリ（アミノアルキレン）マトリックスおよびその使用
JP2008510860A (ja) * 2004-08-27 2008-04-10 ヴァーサマトリックス・アクティーゼルスカブ 高負荷官能性樹脂
WO2006021218A1 (en) * 2004-08-27 2006-03-02 Versamatrix A/S Polyether polymer matrix
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
JP4547620B2 (ja) * 2004-12-02 2010-09-22 日東紡績株式会社 架橋アリルアミン類重合体の製造方法
MY144940A (en) * 2005-01-25 2011-11-30 Avantor Performance Mat Inc Chromatographic media
JP2008533272A (ja) * 2005-03-16 2008-08-21 ユーエスヴィー リミテッド 架橋ポリアリルアミンポリマーの調製のための改良された方法
EP1951266A2 (de) 2005-09-02 2008-08-06 Genzyme Corporation Verfahren zur entfernung von phosphat und dafür verwendetes polymer
AR056499A1 (es) * 2005-09-06 2007-10-10 Serapis Farmaceuticals Ltd Compuestos
BRPI0616078B8 (pt) 2005-09-15 2021-05-25 Genzyme Corp pó de uma formulação farmacêutica de polímero de amina, uso de tal pó e formulação em sachê para polímeros de amina
AU2006299449B2 (en) * 2005-09-30 2013-07-04 Relypsa, Inc. Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal
CA2624112A1 (en) * 2005-09-30 2007-04-05 Ilypsa, Inc. Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
EP1948599A1 (de) 2005-11-08 2008-07-30 Ranbaxy Laboratories Limited Verfahren zur herstellung von (3r,5r)-7-[2-(4-fluorphenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxymethylphenylamino)carbonyl]pyrrol-1-yl]-3,5-dihydroxyheptansäure-hemicalciumsalz
EP2016114A2 (de) * 2006-05-05 2009-01-21 Genzyme Corporation Aminkondensationspolymere als phosphatkomplexbildner
WO2007145308A1 (ja) 2006-06-16 2007-12-21 Mitsubishi Tanabe Pharma Corporation 糸球体疾患の予防及び/または治療剤
FR2902799B1 (fr) 2006-06-27 2012-10-26 Millipore Corp Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide
EP2041261A4 (de) * 2006-07-13 2012-07-04 Ass For Public Health Services Impfösenkonstruktion
EP2049014A2 (de) * 2006-07-18 2009-04-22 Genzyme Corporation Amindendrimere
JP2010504975A (ja) 2006-09-29 2010-02-18 ゲンズイメ コーポレーション アミドデンドリマー組成物
US8163799B2 (en) 2006-12-14 2012-04-24 Genzyme Corporation Amido-amine polymer compositions
WO2008079280A1 (en) 2006-12-21 2008-07-03 Millipore Corporation Purification of proteins
US8569464B2 (en) 2006-12-21 2013-10-29 Emd Millipore Corporation Purification of proteins
US8362217B2 (en) 2006-12-21 2013-01-29 Emd Millipore Corporation Purification of proteins
WO2008103368A1 (en) * 2007-02-23 2008-08-28 Genzyme Corporation Amine polymer compositions
WO2008109095A1 (en) * 2007-03-08 2008-09-12 Genzyme Corporation Sulfone polymer compositions
WO2008133954A1 (en) * 2007-04-27 2008-11-06 Genzyme Corporation Amido-amine dendrimer compositions
EP2016947A1 (de) * 2007-07-17 2009-01-21 Chemo Ibérica, S.A. Neuartiges Verfahren zur Herstellung vernetzter Poly(allylamin-)Polymere in einem einzigen Schritt
PA8807201A1 (es) * 2007-12-14 2009-07-23 Genzyme Corp Composiciones farmaceuticas
US20100316589A1 (en) * 2007-12-14 2010-12-16 Hitesh Bhagat Coated Pharmaceutical Compositions
US8999702B2 (en) 2008-06-11 2015-04-07 Emd Millipore Corporation Stirred tank bioreactor
WO2009154747A1 (en) * 2008-06-20 2009-12-23 Genzyme Corporation Pharmaceutical compositions
DE102008030046A1 (de) 2008-06-25 2009-12-31 Ratiopharm Gmbh Kompaktiertes Polyallylamin-Polymer
KR102178208B1 (ko) * 2008-08-22 2020-11-12 리립사, 인크. 가교결합된 양이온교환 폴리머, 조성물 및 고칼륨혈증 치료 용도
US20100104527A1 (en) * 2008-08-22 2010-04-29 Relypsa, Inc. Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties
US8337824B2 (en) 2008-08-22 2012-12-25 Relypsa, Inc. Linear polyol stabilized polyfluoroacrylate compositions
RU2011112694A (ru) 2008-09-02 2012-10-10 Юсв Лимитед (In) Сшитые полимеры
US20120009242A1 (en) * 2008-11-03 2012-01-12 University Of Maryland, College Park Blood coagulation inducing polymer hydrogel
US8404784B2 (en) * 2008-12-03 2013-03-26 Navinta Llc Manufacturing process of making polymeric amine salts
CN105037535A (zh) 2008-12-16 2015-11-11 Emd密理博公司 搅拌槽反应器及方法
US8673272B2 (en) * 2009-07-27 2014-03-18 Isp Investments Inc. Ultraviolet-absorbing compounds
GB0915449D0 (en) * 2009-09-04 2009-10-07 Univ Robert Gordon Composition
WO2011106542A2 (en) 2010-02-24 2011-09-01 Relypsa, Inc. Crosslinked polyvrnylamine, poly all ylamine, and polyethyleneimine for use as bile acid sequestrants
CN102906159B (zh) * 2010-02-24 2017-09-26 瑞立普萨公司 用作胆汁酸螯合剂的胺聚合物
EP2571903B1 (de) * 2010-05-17 2019-09-04 EMD Millipore Corporation Stimulusreaktive polymere zur aufreinigung von biomolekülen
TR201005327A2 (tr) 2010-06-30 2012-01-23 Bi̇lgi̇ç Mahmut Sinerjik farmasötik formülasyonlar.
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
SG190029A1 (en) 2010-11-08 2013-06-28 Albireo Ab Ibat inhibitors for the treatment of liver diseases
PT2637646T (pt) 2010-11-08 2016-08-17 Albireo Ab Uma combinação farmacêutica que compreende um inibidor do ibat e um sequestrador de ácido biliar
BR112014010223B8 (pt) 2011-10-28 2021-02-23 Lumena Pharmaceuticals Llc uso de uma composição compreendendo inibidores de reciclagem de ácido de bílis e forma de dosagem pediátrica
US20130123433A1 (en) 2011-11-14 2013-05-16 Formosa Laboratories, Inc. Method for preparing poly(allylamine) hydrochloride and derivatives therefrom
CN104822383A (zh) 2012-10-08 2015-08-05 瑞立普萨公司 治疗高血压和高血钾症的钾结合剂
ES2471340B1 (es) 2012-12-21 2015-08-17 Laboratorios Rubió, S.A. Composición farmacéutica oral para fármacos de elevada posología
CN105073728A (zh) * 2013-03-15 2015-11-18 全球血液疗法股份有限公司 化合物及其用于调节血红蛋白的用途
CN103446179B (zh) * 2013-05-14 2017-03-15 厦门绿洲安源投资管理有限公司 作为磷酸盐、脂肪酸和胆汁酸绑定螯合剂的双亲聚富勒烯树状交联聚阳离子凝胶的应用
CA2912911C (en) 2013-06-05 2023-10-03 Tricida, Inc. Proton-binding polymers for oral administration
US9475891B2 (en) 2013-09-19 2016-10-25 Navinta, Llc Process for the preparation of colesevelam hydrochloride
EP2875807B1 (de) 2013-11-20 2021-03-24 Sanovel Ilac Sanayi ve Ticaret A.S. Tablettenformulierung von colesevelam
ITMI20132132A1 (it) 2013-12-19 2015-06-20 Chemi Spa Processo per la preparazione di colesevelam
ES2908142T3 (es) 2014-06-13 2022-04-27 United Therapeutics Corp Formulaciones de treprostinil
EP3229816B1 (de) * 2014-12-10 2020-02-05 Tricida Inc. Protonenbindende polymere zur oralen verabreichung
EP3261624A1 (de) 2015-02-23 2018-01-03 Amneal Pharmaceuticals Company GmbH Verfahren zum granulieren von sevelamerkarbonat
SG10202108228PA (en) 2015-10-21 2021-08-30 Saudi Arabian Oil Co Cationic polymers and porous materials
US20200054669A1 (en) 2016-05-06 2020-02-20 Tricida, Inc. Compositions for and methods of treating acid-base disorders
CN106008813B (zh) * 2016-06-15 2017-11-14 新发药业有限公司 溶液聚合制备盐酸考来维仑的方法
JP7418211B2 (ja) 2016-12-14 2024-01-19 エコラブ ユーエスエイ インク 四級カチオン性ポリマー
CN107232191B (zh) * 2017-06-22 2021-05-18 华中师范大学 一种全氟丁基改性聚乙烯亚胺大分子含氟表面活性剂及其制备与在农药缓释中的应用
AU2018360867A1 (en) 2017-11-03 2020-04-30 Tricida, Inc. Compositions for and method of treating acid-base disorders
WO2019241056A1 (en) 2018-06-12 2019-12-19 Ecolab Usa Inc. Quaternary cationic surfactants and polymers for use as release and coating modifying agents in creping and tissue papers
CN112047854B (zh) * 2020-10-20 2021-07-02 中国科学院长春应用化学研究所 一种n-乙烯基烷基酰胺的制备方法

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE580490A (fr) * 1958-07-15 1960-01-08 Merck & Co Inc Compositions et procédés pour abaisser la teneur en cholestérol du sang
US3308020A (en) * 1961-09-22 1967-03-07 Merck & Co Inc Compositions and method for binding bile acids in vivo including hypocholesteremics
US3383281A (en) * 1961-09-22 1968-05-14 Merck & Co Inc Method for binding bile acids in vivo
US3288770A (en) * 1962-12-14 1966-11-29 Peninsular Chem Res Inc Water soluble quaternary ammonium polymers
BE756035A (fr) * 1969-09-12 1971-03-11 Inveresk Res Int Polymeres pontes
US3803237A (en) * 1969-11-03 1974-04-09 Upjohn Co Reaction products of polyethylenepolyamines and chlorohydrins or epoxy containing compounds
NL7017227A (de) * 1969-12-27 1971-06-29
US3692895A (en) * 1970-09-08 1972-09-19 Norman A Nelson Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria
US3980770A (en) * 1971-06-04 1976-09-14 Pharmacia Aktiebolag Polymerization products containing amino groups useful in serum cholesterol level control
AR206390A1 (es) 1973-02-05 1976-07-23 Rohm & Haas Una matriz de resina polimerica reticulada y procedimiento para su preparacion
US4217429A (en) * 1973-06-11 1980-08-12 Merck & Co., Inc. Poly-[(methylimino)trimethylene]
US4205064A (en) * 1973-06-11 1980-05-27 Merck & Co., Inc. Bile acid sequestering composition containing poly[{alkyl-(3-ammoniopropyl)imino}-trimethylenedihalides]
US4027009A (en) * 1973-06-11 1977-05-31 Merck & Co., Inc. Compositions and methods for depressing blood serum cholesterol
CS187563B1 (en) * 1974-02-08 1979-02-28 Petr Strop Method of preparation of the hydrophilic homogeneous or macroporous annexes
CS173201B1 (de) * 1974-02-13 1977-02-28
US4016209A (en) * 1975-04-23 1977-04-05 Merck & Co., Inc. 3-[N'-(3-Halopropyl)-N-'-methylamino]-N,N,N-trimethyl-1-propanaminium halide and acid addition salts thereof
US4101478A (en) * 1976-04-12 1978-07-18 Kostjuchenko Vladimir Mitrofan Synthetic rubber mix
US4071478A (en) * 1976-06-07 1978-01-31 Merck & Co., Inc. Controlled partially cross-linked 3,3-ionenes
FI67483C (fi) * 1977-02-17 1985-04-10 Merck & Co Inc Foerfarande foer framstaellning av ett icke adhesivt friflytande farmakologiskt godtagbart gallsyrakomplexbildande adsorbatpreparat
US4298715A (en) * 1978-03-01 1981-11-03 Monsanto Company Polyamine/epihalohydrin reaction products
JPS5566513A (en) * 1978-11-14 1980-05-20 Ono Pharmaceut Co Ltd Drug for arteriosclerosis comprising high polymer compound as active constituent
IT1106718B (it) * 1978-12-21 1985-11-18 Alfa Farmaceutici Spa Composizioni a base di resine anioniche salificate farmacologicamente attive
EP0098884B1 (de) * 1982-01-18 1986-07-23 Mitsubishi Petrochemical Co., Ltd. Heilmittel zum absenken cholesterolspiegels
JPS6090243A (ja) * 1983-10-25 1985-05-21 Nitto Boseki Co Ltd 小球状モノアリルアミン橋かけ重合体の製造方法
AU551886B2 (en) * 1983-11-14 1986-05-15 Nitto Boseki Co. Ltd. Poly(allylamine) derivatives
JPS60106803A (ja) * 1983-11-14 1985-06-12 Nitto Boseki Co Ltd アリル尿素重合体の製造方法
CA1220897A (en) * 1984-01-11 1987-04-21 Kiyoshi Shimizu Process for producing polymers of monoallylamine
DE3572985D1 (en) * 1984-05-11 1989-10-19 Bristol Myers Co Novel bile sequestrant resin and uses
US4759923A (en) * 1987-06-25 1988-07-26 Hercules Incorporated Process for lowering serum cholesterol using poly(diallylmethylamine) derivatives
US5300566A (en) * 1988-04-15 1994-04-05 Air Products And Chemicals, Inc. Method for preparing poly(vinyl alcohol)-co-poly(vinylamine) via a two-phase process
DE3901527A1 (de) 1989-01-20 1990-07-26 Hoechst Ag Alkylierte polyethyleniminderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel sowie pharmazeutische praeparate
US5236701A (en) * 1989-07-19 1993-08-17 Lowchol Scientific Inc. Ingestible hydrophilic polymeric amines useful for lowering blood cholesterol
GB8928278D0 (en) * 1989-12-14 1990-02-21 Smith Kline French Lab Compounds
GB9011332D0 (en) * 1990-05-21 1990-07-11 Smith Kline French Lab Compounds
IE914179A1 (en) * 1990-12-07 1992-06-17 Ici Plc Nitrogen derivatives
US5055197A (en) * 1991-04-05 1991-10-08 Rohm And Haas Company Process for removing residual monomers and oligemers from amine-containing polymers
US5142019A (en) * 1991-10-03 1992-08-25 Ppg Industries, Inc. Oligomers formed from reaction of acrylamidoglycolate alkyl ethers with β-hydroxyalkylamines
DK0580078T3 (da) * 1992-07-22 1998-05-25 Hoechst Ag Polyvinylamin-derivater med hydrofyle centrer,fremgangsmåde til deres fremstilling samt anvendelse af forbindelserne som lægemidler, bærere af aktive stoffer og næringsmiddelhjælpestof.
ES2096150T3 (es) * 1992-07-22 1997-03-01 Hoechst Ag Copolimeros vinilicos reticulados, procedimiento para su preparacion, asi como el empleo de estos compuestos.
JP3412842B2 (ja) * 1992-07-28 2003-06-03 ミヨシ油脂株式会社 金属捕集剤及びその製造方法
NZ255758A (en) * 1992-08-20 1997-10-24 Du Pont Crosslinked polymeric ammonium salts useful as bile sequestrants
US5451397A (en) * 1992-12-21 1995-09-19 Rohm And Haas Company Bile acid sequestrant
EP0706399A4 (de) * 1993-06-02 1998-08-12 Geltex Pharma Inc Präparate und verfahren zur entfernung von gallensalzen
US5607669A (en) 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
US5624963A (en) 1993-06-02 1997-04-29 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5703188A (en) 1993-06-02 1997-12-30 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5667775A (en) * 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5414068A (en) * 1994-01-24 1995-05-09 Rohm And Haas Company Crosslinked anion exchange particles and method for producing the particles
TW474813B (en) 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient

Also Published As

Publication number Publication date
US7399821B2 (en) 2008-07-15
US20020095002A1 (en) 2002-07-18
JPH10501842A (ja) 1998-02-17
AU2699095A (en) 1996-01-05
EP0909768A3 (de) 2001-01-17
ES2135743T3 (es) 1999-11-01
GR3031702T3 (en) 2000-02-29
IL114073A (en) 2003-06-24
FR04C0021I1 (de) 2007-10-26
EP0909768A2 (de) 1999-04-21
KR100271693B1 (ko) 2000-11-15
US7101960B2 (en) 2006-09-05
CN1150217C (zh) 2004-05-19
US6066678A (en) 2000-05-23
DE69511861T2 (de) 2000-02-10
IL142419A0 (en) 2002-03-10
US6433026B2 (en) 2002-08-13
NL300159I1 (nl) 2004-11-01
DE122004000034I2 (de) 2006-04-27
AU698752B2 (en) 1998-11-05
LU91100I9 (de) 2019-01-29
DK0764174T3 (da) 2000-03-27
AU698752C (en) 2002-08-08
US5693675A (en) 1997-12-02
FR04C0021I2 (fr) 2008-05-16
DE69511861D1 (de) 1999-10-07
US6784254B2 (en) 2004-08-31
EP0764174A1 (de) 1997-03-26
IL114073A0 (en) 1995-10-31
US20050131161A1 (en) 2005-06-16
CN1150435A (zh) 1997-05-21
CA2191478A1 (en) 1995-12-21
US20070155950A1 (en) 2007-07-05
US6225355B1 (en) 2001-05-01
LU91100I2 (fr) 2004-11-08
ATE184027T1 (de) 1999-09-15
NL300159I2 (nl) 2004-12-01
US5917007A (en) 1999-06-29
US20040014899A1 (en) 2004-01-22
RU2160742C2 (ru) 2000-12-20
US5679717A (en) 1997-10-21
TW474813B (en) 2002-02-01
US20010044519A1 (en) 2001-11-22
US5981693A (en) 1999-11-09
EP0764174B1 (de) 1999-09-01
US20090155201A1 (en) 2009-06-18
CA2191478C (en) 2007-10-16
WO1995034585A1 (en) 1995-12-21
JP3931217B2 (ja) 2007-06-13
NZ288076A (en) 1998-08-26
MX9606171A (es) 1998-07-31

Similar Documents

Publication Publication Date Title
DE122004000034I1 (de) Verfahren zur entfernung von Gallsa}re von einem Patienten sowie die alkylierte zusammensetzungen dafür.
RU96124807A (ru) Способ удаления из организма человека солей желчных кислот и алкилированные композиции для этого способа
DE69326341D1 (de) Poly-3-hydroxyalkanoate und verfahren zu ihrer herstellung
IL133434A0 (en) Polyallylamine polymers for treating hypercholesterolemia
MX9606172A (es) Polimeros reticulados para retirar sales biliares de un paciente.
EP0835888A3 (de) Unvernetztes Anion-Austauscherharz und diesen enthaltende pharmazeutische Zusammensetzung
ATE109788T1 (de) 2'-o-alkylnukleotide sowie polymere, die solche nukleotide enthalten.
ATE298322T1 (de) Ss'-bis-(alpha, alpha'-disubstituierte-alpha''- essigsäure)-trithio-carbonate und derivate davon als initiatoren, kettentransfer-verbindung, kettenabbruch-verbindung für kontrollierte radikalische polymerisationen sowie verfahren zu deren herstellung
BR9404882A (pt) Processo para a preparação de alcoxilatos
RU96124822A (ru) Поперечно-сшитые полимеры для удаления из организма человека солей желчных кислот
DE69609642D1 (de) Polymersalze von Dithiocarbamosäure und Anwendungsverfahren
EP0266906A3 (de) Methode und Zusammensetzung zum Verhindern der Polmerisation eines Acrylesters
EP0330413A3 (de) Verfahren zur Unterdrückung von Krusten, Zusammensetzungen und Verfahren zur Herstellung dieser Zusammensetzungen
EP0205319A3 (de) Polymerzusammensetzung für Photoresistanwendung
CA2151728A1 (fr) Monomere presentant au moins une fonction isocyanate et une insaturation, son procede de synthese et (co)polymeres en decoulant
HRP921337B1 (en) Complex salts of hematoporphyrin and of its derivatives, their synthesis and therapeutic agent
FR2527230B1 (fr) Bains de revetement de zinc, renfermant des brillanteurs formes de derives d'acide a-aminopropionique et de leurs polymeres
WO2000014064A3 (de) Gaba-uptake-inhibitoren mit pyrrolidinstruktur
IT1241987B (it) Sali d'ammonio parzialmente metallizzati di prodotti di condensazione contenenti gruppi solfo. (caso 150-5346).